{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:04:43Z","timestamp":1792919083796,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81971653"],"award-info":[{"award-number":["81971653"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82572319"],"award-info":[{"award-number":["82572319"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M762244"],"award-info":[{"award-number":["2024M762244"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Post Doctor Research Fund of West China Hospital, Sichuan University","award":["2025HXBH087"],"award-info":[{"award-number":["2025HXBH087"]}]},{"name":"Residency Research Foundation of West China Hospital, Sichuan University","award":["GP202601202416"],"award-info":[{"award-number":["GP202601202416"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00259-026-07978-0","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:34:12Z","timestamp":1780464852000},"page":"6375-6385","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CXCR4-targeted [68Ga]Ga-PentixaFor PET\/CT improves staging and alters management in marginal zone lymphoma: a prospectively recruited head-to-head study with [18F]FDG"],"prefix":"10.1007","volume":"53","author":[{"given":"Zitong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhao","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hexiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5191-9004","authenticated-orcid":false,"given":"Rong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"7978_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3324\/haematol.2021.278755","volume":"107","author":"CY Cheah","year":"2022","unstructured":"Cheah CY, Zucca E, Rossi D, Habermann TM. Marginal zone lymphoma: present status and future perspectives. Haematologica. 2022;107:35\u201343. https:\/\/doi.org\/10.3324\/haematol.2021.278755.","journal-title":"Haematologica"},{"key":"7978_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1182\/hematology.2022000362","volume":"2022","author":"M Merli","year":"2022","unstructured":"Merli M, Arcaini L. Management of marginal zone lymphomas. Hematol Am Soc Hematol Educ Program. 2022;2022:676\u201387. https:\/\/doi.org\/10.1182\/hematology.2022000362.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"7978_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.70289","author":"WD Noor","year":"2026","unstructured":"Noor WD, Seymour JF, Cheah CY. Marginal Zone Lymphoma: 2026 Update on Diagnosis and Management. Am J Hematol. 2026. https:\/\/doi.org\/10.1002\/ajh.70289.","journal-title":"Am J Hematol"},{"key":"7978_CR4","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1007\/s00330-024-11213-5","volume":"35","author":"D Leithner","year":"2025","unstructured":"Leithner D, Neri E, D\u2019Anastasi M, Schlemmer HP, Winkelmann M, Kunz WG, et al. ESR Essentials: imaging of lymphoma-practice recommendations by the European Society of Oncologic Imaging. Eur Radiol. 2025;35:4387\u201394. https:\/\/doi.org\/10.1007\/s00330-024-11213-5.","journal-title":"Eur Radiol"},{"key":"7978_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/hon.2181","volume":"33","author":"E Carrillo-Cruz","year":"2015","unstructured":"Carrillo-Cruz E, Mar\u00edn-Oyaga VA, de la Cruz Vicente F, Borrego-Dorado I, Ruiz Mercado M, Acevedo B\u00e1\u00f1ez I, et al. Role of 18F-FDG-PET\/CT in the management of marginal zone B cell lymphoma. Hematol Oncol. 2015;33:151\u20138. https:\/\/doi.org\/10.1002\/hon.2181.","journal-title":"Hematol Oncol"},{"key":"7978_CR6","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/ajh.27712","volume":"100","author":"JP Alderuccio","year":"2025","unstructured":"Alderuccio JP, Kuker RA, Edelman Saul E, Stanchina MD, Polar MK, Chapman J, et al. PET\/CT in the Staging and Treatment Response Assessment of Patients With Extranodal Marginal Zone Lymphoma. Am J Hematol. 2025;100:1295\u2013304. https:\/\/doi.org\/10.1002\/ajh.27712.","journal-title":"Am J Hematol"},{"key":"7978_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.clml.2019.10.006","volume":"20","author":"D Albano","year":"2020","unstructured":"Albano D, Durmo R, Treglia G, Giubbini R, Bertagna F. (18)F-FDG PET\/CT or PET Role in MALT Lymphoma: An Open Issue not Yet Solved-A Critical Review. Clin lymphoma myeloma Leuk. 2020;20:137\u201346. https:\/\/doi.org\/10.1016\/j.clml.2019.10.006.","journal-title":"Clin lymphoma myeloma Leuk"},{"key":"7978_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","volume":"31","author":"E Zucca","year":"2020","unstructured":"Zucca E, Arcaini L, Buske C, Johnson PW, Ponzoni M, Raderer M, et al. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals oncology: official J Eur Soc Med Oncol. 2020;31:17\u201329. https:\/\/doi.org\/10.1016\/j.annonc.2019.10.010.","journal-title":"Annals oncology: official J Eur Soc Med Oncol"},{"key":"7978_CR9","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s00432-016-2220-6","volume":"142","author":"S Stollberg","year":"2016","unstructured":"Stollberg S, K\u00e4mmerer D, Neubauer E, Schulz S, Simonitsch-Klupp I, Kiesewetter B, et al. Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin. J Cancer Res Clin Oncol. 2016;142:2239\u201347. https:\/\/doi.org\/10.1007\/s00432-016-2220-6.","journal-title":"J Cancer Res Clin Oncol"},{"key":"7978_CR10","doi-asserted-by":"publisher","first-page":"710900","DOI":"10.3389\/fonc.2021.710900","volume":"11","author":"T Juntikka","year":"2021","unstructured":"Juntikka T, Vaittinen S, Vahlberg T, Jyrkki\u00f6 S, Minn H. Somatostatin Receptors and Chemokine Receptor CXCR4 in Lymphomas: A Histopathological Review of Six Lymphoma Subtypes. Front Oncol. 2021;11:710900. https:\/\/doi.org\/10.3389\/fonc.2021.710900.","journal-title":"Front Oncol"},{"key":"7978_CR11","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s11307-022-01717-1","volume":"24","author":"SE Serfling","year":"2022","unstructured":"Serfling SE, Lapa C, Dreher N, Hartrampf PE, Rowe SP, Higuchi T, et al. Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [(68)Ga]Ga-PentixaFor PET\/CT. Mol imaging biology. 2022;24:659\u201365. https:\/\/doi.org\/10.1007\/s11307-022-01717-1.","journal-title":"Mol imaging biology"},{"key":"7978_CR12","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2967\/jnumed.121.263693","volume":"63","author":"AK Buck","year":"2022","unstructured":"Buck AK, Haug A, Dreher N, Lambertini A, Higuchi T, Lapa C, et al. Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using (68)Ga-PentixaFor PET. J Nucl Med. 2022;63:1687\u201392. https:\/\/doi.org\/10.2967\/jnumed.121.263693.","journal-title":"J Nucl Med"},{"key":"7978_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1182\/blood.2021013239","volume":"139","author":"ME Mayerhoefer","year":"2022","unstructured":"Mayerhoefer ME, Raderer M, Lamm W, Weber M, Kiesewetter B, Rohrbeck J, et al. CXCR4 PET\/MRI for follow-up of gastric mucosa-associated lymphoid tissue lymphoma after first-line Helicobacter pylori eradication. Blood. 2022;139:240\u20134. https:\/\/doi.org\/10.1182\/blood.2021013239.","journal-title":"Blood"},{"key":"7978_CR14","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1097\/rlu.0000000000005426","volume":"50","author":"M Chavoshi","year":"2025","unstructured":"Chavoshi M, Mirshahvalad SA, Kohan A, Ortega C, Metser U, Farag A, et al. CXCR4-Targeted PET Imaging in Hematologic Malignancies: A Systematic Review and Meta-analysis. Clin Nucl Med. 2025;50:e7\u201316. https:\/\/doi.org\/10.1097\/rlu.0000000000005426.","journal-title":"Clin Nucl Med"},{"key":"7978_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13550-017-0294-z","volume":"7","author":"P Herhaus","year":"2017","unstructured":"Herhaus P, Habringer S, Vag T, Steiger K, Slotta-Huspenina J, Gerngro\u00df C, et al. Response assessment with the CXCR4-directed positron emission tomography tracer [(68)Ga]Pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavities. EJNMMI Res. 2017;7:51. https:\/\/doi.org\/10.1186\/s13550-017-0294-z.","journal-title":"EJNMMI Res"},{"key":"7978_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13550-020-00681-7","volume":"10","author":"Q Pan","year":"2020","unstructured":"Pan Q, Luo Y, Zhang Y, Chang L, Li J, Cao X, et al. Preliminary evidence of imaging of chemokine receptor-4-targeted PET\/CT with [(68)Ga]pentixafor in non-Hodgkin lymphoma: comparison to [(18)F]FDG. EJNMMI Res. 2020;10:89. https:\/\/doi.org\/10.1186\/s13550-020-00681-7.","journal-title":"EJNMMI Res"},{"key":"7978_CR17","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.120.257279","volume":"62","author":"J Duell","year":"2021","unstructured":"Duell J, Krummenast F, Schirbel A, Klassen P, Samnick S, Rauert-Wunderlich H, et al. Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET\/CT. J Nucl Med. 2021;62:1415\u201321. https:\/\/doi.org\/10.2967\/jnumed.120.257279.","journal-title":"J Nucl Med"},{"key":"7978_CR18","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.2967\/jnumed.123.266074","volume":"64","author":"J Duell","year":"2023","unstructured":"Duell J, Buck AK, Hartrampf PE, Schl\u00f6telburg W, Schneid S, Weich A, et al. Chemokine Receptor PET\/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma. J Nucl Med. 2023;64:1889\u201394. https:\/\/doi.org\/10.2967\/jnumed.123.266074.","journal-title":"J Nucl Med"},{"key":"7978_CR19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/rlu.0000000000004629","volume":"48","author":"PE Hartrampf","year":"2023","unstructured":"Hartrampf PE, Kosmala A, Serfling SE, Bundschuh L, Higuchi T, Lapa C, et al. Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4-Directed Molecular Imaging and Therapy. Clin Nucl Med. 2023;48:483\u20138. https:\/\/doi.org\/10.1097\/rlu.0000000000004629.","journal-title":"Clin Nucl Med"},{"key":"7978_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/hon.2578","volume":"37","author":"I Vaxman","year":"2019","unstructured":"Vaxman I, Bernstine H, Kleinstern G, Hendin N, Shimony S, Domachevsky L, et al. FDG PET\/CT as a diagnostic and prognostic tool for the evaluation of marginal zone lymphoma. Hematol Oncol. 2019;37:168\u201375. https:\/\/doi.org\/10.1002\/hon.2578.","journal-title":"Hematol Oncol"},{"key":"7978_CR21","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00259-023-06489-6","volume":"51","author":"A Kosmala","year":"2024","unstructured":"Kosmala A, Duell J, Schneid S, Serfling SE, Higuchi T, Weich A, et al. Chemokine receptor-targeted PET\/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [(18)F]FDG. Eur J Nucl Med Mol Imaging. 2024;51:749\u201355. https:\/\/doi.org\/10.1007\/s00259-023-06489-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7978_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1053\/j.semnuclmed.2023.09.002","volume":"54","author":"L Lindenberg","year":"2024","unstructured":"Lindenberg L, Ahlman M, Lin F, Mena E, Choyke P. Advances in PET Imaging of the CXCR4 Receptor: [(68)Ga]Ga-PentixaFor. Semin Nucl Med. 2024;54:163\u201370. https:\/\/doi.org\/10.1053\/j.semnuclmed.2023.09.002.","journal-title":"Semin Nucl Med"},{"key":"7978_CR23","doi-asserted-by":"publisher","unstructured":"Pansy K, Feichtinger J, Ehall B, Uhl B, Sedej M, Roula D, et al. The CXCR4-CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro. Int J Mol Sci. 2019;20. https:\/\/doi.org\/10.3390\/ijms20194740.","DOI":"10.3390\/ijms20194740"},{"key":"7978_CR24","doi-asserted-by":"publisher","first-page":"717","DOI":"10.18632\/oncotarget.26588","volume":"10","author":"MB Laursen","year":"2019","unstructured":"Laursen MB, Reinholdt L, Sch\u00f6nherz AA, Due H, Jespersen DS, Grubach L, et al. High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients. Oncotarget. 2019;10:717\u201331. https:\/\/doi.org\/10.18632\/oncotarget.26588.","journal-title":"Oncotarget"},{"key":"7978_CR25","doi-asserted-by":"publisher","unstructured":"Giorgiutti S, Rottura J, Korganow AS, Gies V. CXCR4: from B-cell development to B cell-mediated diseases. Life Sci alliance. 2024;7. https:\/\/doi.org\/10.26508\/lsa.202302465.","DOI":"10.26508\/lsa.202302465"},{"key":"7978_CR26","doi-asserted-by":"publisher","unstructured":"Park JB, Koo JS. Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue lymphoma. World journal of gastroenterology. 2014;20:2751-9. https:\/\/doi.org\/10.3748\/wjg.v20.i11.2751.and read and approved the final version of the manuscript.","DOI":"10.3748\/wjg.v20.i11.2751"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07978-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07978-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07978-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:00:40Z","timestamp":1787986840000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07978-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["7978"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07978-0","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This prospectively recruiting study was approved by the West China Hospital Clinical Trials and Biomedical Ethics Committee, Sichuan University (Approval in 2023, No. 1340).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants prior to enrollment.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Registered at www.chictr.org.cn (identifier: ChiCTR2400081464).","order":4,"name":"Ethics","label":"Clinical trial registration","group":{"name":"EthicsHeading","label":"Declarations"}}]}}